Molecular mechanism of the inhibition and remodeling of human islet amyloid polypeptide (hIAPP1-37) oligomer by resveratrol from molecular dynamics simulation

Journal of Physical Chemistry B

Volumn 119, Issue 1, 2015, Pages 15-24

  Wang, Qianqian ^a   Ning, Lulu ^b   Niu, Yuzhen ^b   Liu, Huanxiang ^a,b   Yao, Xiaojun ^b,c  

^a LANZHOU UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

^c MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; FREE ENERGY; GLYCOPROTEINS; MOLECULAR DYNAMICS; OLIGOMERS; RESVERATROL;

BINDING FREE ENERGY; CLUSTERING ANALYSIS; CONFORMATIONAL CHANGE; ENERGY DECOMPOSITION; INHIBITORY MECHANISM; MOLECULAR DYNAMICS SIMULATIONS; NONPOLAR INTERACTIONS; SECONDARY STRUCTURES;

BINDING SITES;

AMYLIN; POLYPHENOL;

ANTAGONISTS AND INHIBITORS; CHEMISTRY; HUMAN; MOLECULAR DYNAMICS;

HUMANS; ISLET AMYLOID POLYPEPTIDE; MOLECULAR DYNAMICS SIMULATION; POLYPHENOLS;

EID: 84920717776     PISSN: 15206106     EISSN: 15205207     Source Type: Journal    
DOI: 10.1021/jp507529f     Document Type: Article

References (65)

1. Dobson, C. M. Protein Folding and Misfolding. Nature 2003, 426, 884-890.
2. Sawaya, M. R.; Sambashivan, S.; Nelson, R.; Ivanova, M. I.; Sievers, S. A.; Apostol, M. I.; Thompson, M. J.; Balbirnie, M.; Wiltzius, J. J.; McFarlane, H. T.; et al. Atomic Structures of Amyloid Cross-Beta Spines Reveal Varied Steric Zippers. Nature 2007, 447, 453-457.
3. Taylor, J. P.; Hardy, J.; Fischbeck, K. H. Toxic Proteins in Neurodegenerative Disease. Science 2002, 296, 1991-1995.
4. Karran, E.; Mercken, M.; De Strooper, B. The Amyloid Cascade Hypothesis for Alzheimer's Disease: An Appraisal for the Development of Therapeutics. Nat. Rev. Drug Discovery 2011, 10, 698-712.
5. Hardy, J. A.; Higgins, G. A. Alzheimer's Disease: The Amyloid Cascade Hypothesis. Science 1992, 256, 184-185.
6. Hull, R. L.; Westermark, G. T.; Westermark, P.; Kahn, S. E. Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes. J. Clin. Endocrinol. Metab. 2004, 89, 3629-3643.
7. Wei, L.; Jiang, P.; Xu, W.; Li, H.; Zhang, H.; Yan, L.; Chan-Park, M. B.; Liu, X. W.; Tang, K.; Mu, Y.; et al. The Molecular Basis of Distinct Aggregation Pathways of Islet Amyloid Polypeptide. J. Biol. Chem. 2010, 286, 6291-6300.
8. Haataja, L.; Gurlo, T.; Huang, C. J.; Butler, P. C. Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis. Endocr. Rev. 2008, 29, 303-316.
9. Nanga, R. P.; Brender, J. R.; Xu, J.; Veglia, G.; Ramamoorthy, A. Structures of Rat and Human Islet Amyloid Polypeptide IAPP(1-19) in Micelles by NMR Spectroscopy. Biochemistry 2008, 47, 12689-12697.
10. Liang, G.; Zhao, J.; Yu, X.; Zheng, J. Comparative Molecular Dynamics Study of Human Islet Amyloid Polypeptide (IAPP) and Rat IAPP Oligomers. Biochemistry 2013, 52, 1089-1100.
11. Westermark, G. T.; Westermark, P.; Berne, C.; Korsgren, O. Widespread Amyloid Deposition in Transplanted Human Pancreatic Islets. N. Engl. J. Med. 2008, 359, 977-979.
12. Westermark, G. T.; Westermark, P.; Nordin, A.; Tornelius, E.; Andersson, A. Formation of Amyloid in Human Pancreatic Islets Transplanted to the Liver and Spleen of Nude Mice. Ups. J. Med. Sci. 2003, 108, 193-203.
13. Potter, K. J.; Abedini, A.; Marek, P.; Klimek, A. M.; Butterworth, S.; Driscoll, M.; Baker, R.; Nilsson, M. R.; Warnock, G. L.; Oberholzer, J.; et al. Islet Amyloid Deposition Limits the Viability of Human Islet Grafts but Not Porcine Islet Grafts. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 4305-4310.
14. Nguyen, P.; Derreumaux, P. Understanding Amyloid Fibril Nucleation and Aβ Oligomer/Drug Interactions from Computer Simulations. Acc. Chem. Res. 2013, 47, 603-611.
15. Ehrnhoefer, D. E.; Bieschke, J.; Boeddrich, A.; Herbst, M.; Masino, L.; Lurz, R.; Engemann, S.; Pastore, A.; Wanker, E. E. EGCG Redirects Amyloidogenic Polypeptides into Unstructured, Off-Pathway Oligomers. Nat. Struct. Mol. Biol. 2008, 15, 558-566.
16. Ahn, J. H.; Hu, Y.; Hernandez, M.; Kim, J. R. Crocetin Inhibits Beta-Amyloid Fibrillization and Stabilizes Beta-Amyloid Oligomers. Biochem. Biophys. Res. Commun. 2011, 414, 79-83.
17. Lemkul, J. A.; Bevan, D. R. Morin Inhibits the Early Stages of Amyloid Beta-Peptide Aggregation by Altering Tertiary and Quaternary Interactions to Produce "Off-Pathway" Structures. Biochemistry. 2012, 51, 5990-6009.
18. Viet, M. H.; Ngo, S. T.; Lam, N. S.; Li, M. S. Inhibition of Aggregation of Amyloid Peptides by Beta-Sheet Breaker Peptides and Their Binding Affinity. J. Phys. Chem. B 2011, 115, 7433-7446.
19. Stefani, M.; Rigacci, S. Protein Folding and Aggregation into Amyloid: The Interference by Natural Phenolic Compounds. Int. J. Mol. Sci. 2013, 14, 12411-12457.
20. Porat, Y.; Abramowitz, A.; Gazit, E. Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition Mechanism. Chem. Biol. Drug Des. 2006, 67, 27-37.
21. Ono, K.; Li, L.; Takamura, Y.; Yoshiike, Y.; Zhu, L.; Han, F.; Mao, X.; Ikeda, T.; Takasaki, J. i.; Nishijo, H.; et al. Phenolic Compounds Prevent Amyloid beta-Protein Oligomerization and Synaptic Dysfunction by Site-Specific Binding. J. Biol. Chem. 2012, 287, 14631-14643.
22. Baptista, F. I.; Henriques, A. G.; Silva, A. M.; Wiltfang, J.; da Cruz e Silva, O. A. Flavonoids as Therapeutic Compounds Targeting Key Proteins Involved in Alzheimer's Disease. ACS Chem. Neurosci. 2014, 5, 83-92.
23. Queen, B. L.; Tollefsbol, T. O. Polyphenols and Aging. Curr. Aging Sci. 2010, 3, 34-42.
24. Mishra, R.; Sellin, D.; Radovan, D.; Gohlke, A.; Winter, R. Inhibiting Islet Amyloid Polypeptide Fibril Formation by the Red Wine Compound Resveratrol. ChemBioChem 2009, 10, 445-449.
25. Radovan, D.; Opitz, N.; Winter, R. Fluorescence Microscopy Studies on Islet Amyloid Polypeptide Fibrillation at Heterogeneous and Cellular Membrane Interfaces and Its Inhibition by Resveratrol. FEBS Lett. 2009, 583, 1439-1445.
26. Gazova, Z.; Siposova, K.; Kurin, E.; Mučaji, P.; Nagy, M. Amyloid Aggregation of Lysozyme: The Synergy Study of Red Wine Polyphenols. Proteins 2013, 81, 994-1004.
27. Pan, L.-F.; Wang, X.-B.; Xie, S.-S.; Li, S.-Y.; Kong, L.-Y. Multitarget-Directed Resveratrol Derivatives: Anti-Cholinesterases, Anti-Beta-Amyloid Aggregation and Monoamine Oxidase Inhibition Properties against Alzheimer' s Disease. Med. Chem. Commun. 2014, 5, 609-616.
28. Ge, J. F.; Qiao, J. P.; Qi, C. C.; Wang, C. W.; Zhou, J. N. The Binding of Resveratrol to Monomer and Fibril Amyloid Beta. Neurochem. Int. 2012, 61, 1192-1201.
29. Ladiwala, A. R. A.; Lin, J. C.; Bale, S. S.; Marcelino-Cruz, A. M.; Bhattacharya, M.; Dordick, J. S.; Tessier, P. M. Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Beta-Amyloid into Off- Pathway Conformers. J. Biol. Chem. 2010, 285, 24228-24237.
30. Luca, S.; Yau, W. M.; Leapman, R.; Tycko, R. Peptide Conformation and Supramolecular Organization in Amylin Fibrils: Constraints from Solid-State NMR. Biochemistry 2007, 46, 13505-13522.
31. Case, D. A.; Cheatham, T. E., 3rd; Darden, T.; Gohlke, H.; Luo, R.; Merz, K. M., Jr.; Onufriev, A.; Simmerling, C.; Wang, B.; Woods, R. J. The Amber Biomolecular Simulation Programs. J. Comput. Chem. 2005, 26, 1668-1688.
32. Wang, J.; Wolf, R. M.; Caldwell, J. W.; Kollman, P. A.; Case, D. A. Development and Testing of a General Amber Force Field. J. Comput. Chem. 2004, 25, 1157-1174.
33. Bayly, C. I.; Cieplak, P.; Cornell, W.; Kollman, P. A. A Well-Behaved Electrostatic Potential Based Method Using Charge Restraints for Deriving Atomic Charges: The RESP Model. J. Phys. Chem. 1993, 97, 10269-10280.
34. Cieplak, P.; Cornell, W. D.; Bayly, C.; Kollman, P. A. Application of the Multimolecule and Multiconformational Resp Methodology to Biopolymers: Charge Derivation for DNA, RNA, and Proteins. J. Comput. Chem. 1995, 16, 1357-1377.
35. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A. et al. Gaussian 09; Gaussian, Inc.: Wallingford, CT, 2009.
36. Hornak, V.; Abel, R.; Okur, A.; Strockbine, B.; Roitberg, A.; Simmerling, C. Comparison of Multiple Amber Force Fields and Development of Improved Protein Backbone Parameters. Proteins 2006, 65, 712-725.
37. Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of Simple Potential Functions for Simulating Liquid Water. J. Phys. Chem. 1983, 79, 926-935.
38. Jiang, P.; Li, W.; Shea, J.-E.; Mu, Y. Resveratrol Inhibits the Formation of Multiple-Layered Beta-Sheet Oligomers of the Human Islet Amyloid Polypeptide Segment 22-27. Biophys. J. 2011, 100, 1550-1558.
39. Ryckaert, J.-P.; Ciccotti, G.; Berendsen, H. J. C. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of N-Alkanes. J. Comput. Phys. 1977, 23, 327-341.
40. Essmann, U.; Perera, L.; Berkowitz, M. L.; Darden, T.; Lee, H.; Pedersen, L. G. A Smooth Particle Mesh Ewald Method. J. Phys. Chem. 1995, 103, 8577-8593.
41. Hou, T.; Wang, J.; Li, Y.; Wang, W. Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations. J. Chem. Inf. Model. 2011, 51, 69-82.
42. Hou, T.; Wang, J.; Li, Y.; Wang, W. Assessing the Performance of the Molecular Mechanics/Poisson Boltzmann Surface Area and Molecular Mechanics/Generalized Born Surface Area Methods. II. The Accuracy of Ranking Poses Generated from Docking. J. Comput. Chem. 2011, 32, 866-877.
43. Xu, L.; Sun, H.; Li, Y.; Wang, J.; Hou, T. Assessing the Performance of MM/PBSA and MM/GBSA Methods. 3. The Impact of Force Fields and Ligand Charge Models. J. Phys. Chem. B 2013, 117, 8408-8421.
44. Liu, H.; Yao, X. Molecular Basis of the Interaction for an Essential Subunit PA-PB1 in Influenza Virus RNA Polymerase: Insights from Molecular Dynamics Simulation and Free Energy Calculation. Mol. Pharmaceutics 2010, 7, 75-85.
45. Srinivasan, J.; Cheatham, T. E.; Cieplak, P.; Kollman, P. A.; Case, D. A. Continuum Solvent Studies of the Stability of DNA, RNA, and Phosphoramidate-DNA Helices. J. Am. Chem. Soc. 1998, 120, 9401-9409.
46. Sitkoff, D.; Sharp, K. A.; Honig, B. Accurate Calculation of Hydration Free Energies Using Macroscopic Solvent Models. J. Phys. Chem. 1994, 98, 1978-1988.
47. Maffucci, I.; Contini, A. Explicit Ligand Hydration Shells Improve the Correlation between MM-PB/GBSA Binding Energies and Experimental Activities. J. Chem. Theory Comput. 2013, 9, 2706-2717.
48. Qin, B.; Jiang, X.; Lu, H.; Tian, X.; Barbault, F.; Huang, L.; Qian, K.; Chen, C. H.; Huang, R.; Jiang, S.; Lee, K. H.; Xie, L. Diarylaniline Derivatives as a Distinct Class of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. J. Med. Chem. 2010, 53, 4906-4916.
49. Chang, H. W.; Chung, F. S.; Yang, C. N. Molecular Modeling of P38α Mitogen-Activated Protein Kinase Inhibitors through 3D-QSAR and Molecular Dynamics Simulations. J. Chem. Inf. Model. 2013, 53, 1775-1786.
50. Nguyen, P. H.; Li, M. S.; Stock, G.; Straub, J. E.; Thirumalai, D. Monomer Adds to Preformed Structured Oligomers of Abeta-Peptides by a Two-Stage Dock-Lock Mechanism. Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 111-116.
51. Cecchini, M.; Rao, F.; Seeber, M.; Caflisch, A. Replica Exchange Molecular Dynamics Simulations of Amyloid Peptide Aggregation. J. Chem. Phys. 2004, 121, 10748-10756.
52. Amadei, A.; Linssen, A. B. M.; Berendsen, H. J. C. Essential Dynamics of Proteins. Proteins 1993, 17, 412-425.
53. Mu, Y.; Nguyen, P. H.; Stock, G. Energy Landscape of a Small Peptide Revealed by Dihedral Angle Principal Component Analysis. Proteins 2005, 58, 45-52.
54. Sittel, F.; Jain, A.; Stock, G. Principal Component Analysis of Molecular Dynamics: On the Use of Cartesian vs. Internal Coordinates. J. Chem. Phys. 2014, 141, 014111.
55. Altis, A.; Nguyen, P. H.; Hegger, R.; Stock, G. Dihedral Angle Principal Component Analysis of Molecular Dynamics Simulations. J. Chem. Phys. 2007, 126, 244111.
56. Riccardi, L.; Nguyen, P. H.; Stock, G. Free-Energy Landscape of RNA Hairpins Constructed via Dihedral Angle Principal Component Analysis. J. Phys. Chem. B 2009, 113, 16660-16668.
57. Kabsch, W.; Sander, C. Dictionary of Protein Secondary Structure: Pattern Recognition of Hydrogen-Bonded and Geometrical Features. Biopolymers 1983, 22, 2577-2637.
58. Zhao, L. N.; Chiu, S.-W.; Benoit, J.; Chew, L. Y.; Mu, Y. The Effect of Curcumin on the Stability of Aβ Dimers. J. Phys. Chem. B 2012, 116, 7428-7435.
59. Wang, Q.; Guo, J.; Jiao, P.; Liu, H.; Yao, X. Exploring the Influence of EGCG on the Beta-Sheet-Rich Oligomers of Human Islet Amyloid Polypeptide (hIAPP1-37) and Identifying Its Possible Binding Sites from Molecular Dynamics Simulation. PLoS One 2014, 9, e94796.
60. Zhang, T.; Xu, W.; Mu, Y.; Derreumaux, P. Atomic and Dynamic Insights into the Beneficial Effect of the 1,4-Naphthoquinon-2-yl-l-Tryptophan Inhibitor on Alzheimer's Aβ1-42 Dimer in Terms of Aggregation and Toxicity. ACS Chem. Neurosci. 2014, 5, 148-159.
61. Ladiwala, A. R. A.; Dordick, J. S.; Tessier, P. M. Aromatic Small Molecules Remodel Toxic Soluble Oligomers of Amyloid Beta through Three Independent Pathways. J. Biol. Chem. 2010, 286, 3209-3218.
62. Engel, M. F. M.; vandenAkker, C. C.; Schleeger, M.; Velikov, K. P.; Koenderink, G. H.; Bonn, M. The Polyphenol EGCG Inhibits Amyloid Formation Less Efficiently at Phospholipid Interfaces Than in Bulk Solution. J. Am. Chem. Soc. 2012, 134, 14781-14788.
63. Mishra, R.; Sellin, D.; Radovan, D.; Gohlke, A.; Winter, R. Inhibiting Islet Amyloid Polypeptide Fibril Formation by the Red Wine Compound Resveratrol. ChemBioChem 2009, 10, 445-449.
64. Radovan, D.; Opitz, N.; Winter, R. Fluorescence Microscopy Studies on Islet Amyloid Polypeptide Fibrillation at Heterogeneous and Cellular Membrane Interfaces and Its Inhibition by Resveratrol. FEBS Lett. 2009, 583, 1439-1445.
65. Wiltzius, J. J. W.; Sievers, S. A.; Sawaya, M. R.; Cascio, D.; Popov, D.; Riekel, C.; Eisenberg, D. Atomic Structure of the Cross-Beta Spine of Islet Amyloid Polypeptide (Amylin). Protein Sci. 2008, 17, 1467-1474.